510(k) Report

FDA applicant

Hemocue, Inc.

Potomac, MD15 decisions1991–202010 recalls

FDA records 15 decisions for Hemocue, Inc. (Potomac, MD) from 1991 to 2020: 15 510(k) clearances. Most are in product codes GKR (System, Hemoglobin, Automated) and LFR (Glucose Dehydrogenase, Glucose). Its devices cite 5 predicates, 4 of them its own earlier devices. 10 recalls are linked to its devices.

FDA’s records also spell it “Hemocue AB”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Hemocue, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2020

2007: 12019: 12020: 1
2007high 1 (2007) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

2in 2025

2010: 22011: 12012: 12013: 32014: 12025: 2
2007high 3 (2013) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Hemocue, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Hemocue, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report